tiprankstipranks
Mynd Life Sciences Inc (MYNDF)
:MYNDF
US Market
Holding MYNDF?
Track your performance easily

MYND Life Sciences (MYNDF) Financial Statements

1 Followers

MYND Life Sciences Financial Overview

MYND Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.008; its P/E ratio is ―; MYND Life Sciences is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Dec 23Jul 23
Income Statement-
Total Revenue--$ 1.00--
Gross Profit--$ 1.00$ 180.00K$ -60.00K
EBIT$ -341.77K$ -221.23K$ -334.43K$ 589.95K$ -314.44K
EBITDA$ -341.69K$ -220.58K$ -333.78K$ 589.95K$ -314.44K
Net Income Common Stockholders$ -379.27K$ -259.56K$ -372.76K$ 469.04K$ -530.80K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 497.00$ 1.81K$ 265.00$ 257.00$ 172.00
Total Assets$ 719.72K$ 707.95K$ 771.35K$ 797.54K$ 341.62K
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 6.71M$ 6.32M$ 6.12M$ 5.77M$ 5.81M
Stockholders Equity$ -5.99M$ -5.61M$ -5.35M$ -4.98M$ -5.47M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow$ -1.25K$ 39.82K$ -38.32K--
Investing Cash Flow$ -57.00$ 57.00---
Financing Cash Flow-----
Currency in USD

MYND Life Sciences Earnings and Revenue History

MYND Life Sciences Debt to Assets

MYND Life Sciences Cash Flow

MYND Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis